Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts
7 Articles
7 Articles
Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts
Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, as the obesity drugmaker faces growing pressure from U.S. President Donald Trump on drug pricing.
Reuters Health News Summary
The regulator said it has selected Merck KGaA's fertility drug Pergoveris, Sanofi's Type 1 diabetes drug teplizumab, Regeneron's DB-OTO for deafness and ketamine for domestic manufacturing of a general anesthetic. Novo Nordisk hires US pharma veteran as Trump pricing pressure mounts Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, as the obesity drugmaker faces growing pressure from U.S. P…
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium